Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GSK2879552

Inh 1401966-69-5 4-[[4-[[[(1R,2S)-2-Phenylcyclopropyl]amino]methyl]-1-piperidinyl]methyl]benzoic acid dihydrochloride
Produktnummer ABIN7233256
  • Applikation
    Inhibition (Inh)
    Verwendungszweck
    Lysine Demethylase inhibitor
    Produktmerkmale
    GSK289552 is potent, selective, and irreversible inhibitor of Lysine Demethylase 1 (LSD1) via covalent modification of the LSD1 cofactor FAD (Ki = 1.7 μM). It is selective for LSD1 over the closely related LSD2, MAO-A, MAO-B, and the FAD dependent enzymes D-amino acid oxidase and glutathione reductase. Tested against a panel of 165 cancer cell lines, GSK2879552 inhibited the proliferation of 9 small cell lung carcinoma lines and 20 AML cell lines.
    Reinheit
    >98 %
    Chemical Name
    4-[[4-[[[(1R,2S)-2-Phenylcyclopropyl]amino]methyl]-1-piperidinyl]methyl]benzoic acid dihydrochloride
    Formel
    C23H28N2O2 •2HCl
    Löslichkeit
    Soluble in DMSO (up to 25 mg/ml) and in Water (up to at least 25 mg/ml)
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Powder
    Lagerung
    -20 °C
  • Hintergrund
    Epigenetics,Proliferation,Protein demethylase,Cancer,Posttranslational modification,Chromatin
    Molekulargewicht
    437.40
    CAS-Nummer
    1401966-69-5
Sie sind hier: